European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

Ischemic heart disease in Women: are there sex differences in pathophysiology and risk factors?

Position Paper from the Working Group on Coronary Pathophysiology and Microcirculation of the European Society of Cardiology

First published online: 14 December 2010

Access free online article

 

Reference:
Cardiovascular Research (2011) 90, 9–17
doi:10.1093/cvr/cvq394

Authors:
Viola Vaccarino, Lina Badimon, Roberto Corti, Cor de Wit, Maria Dorobantu,
Alistair Hall, Akos Koller, Mario Marzilli, Axel Pries, and Raffaele Bugiardini
on behalf of the Working Group on Coronary Pathophysiology and Microcirculation

Abstract:
Cardiovascular disease (CVD) is the leading cause of death in women, and knowledge of the clinical consequences of atherosclerosis and CVD in women has grown tremendously over the past 20 years. Research efforts have increased and many reports on various aspects of ischaemic heart disease (IHD) in women have been published highlighting sex differences in pathophysiology, presentation, and treatment of IHD. Data, however, remain limited. A description of the state of the science, with recognition of the shortcomings of current data, is necessary to guide future research and move the field forward. In this report, we identify gaps in existing literature and make recommendations for future research. Women largely share similar cardiovascular risk factors for IHD with men; however, women with suspected or confirmed IHD have less coronary atherosclerosis than men, even though they are older and have more cardiovascular risk factors than men. Coronary endothelial dysfunction and microvascular disease have been proposed as important determinants in the aetiology and prognosis of IHD in women, but research is limited on whether sex differences in these mechanisms truly exist. Differences in the epidemiology of IHD between women and men remain largely unexplained, as we are still unable to explain why women are protected towards IHD
until older age compared with men. Eventually, a better understanding of these processes and mechanisms may improve the prevention and the clinical management of IHD in women.



 
Highlight On

Anti-Thrombotic Therapy - Update 2012
07-09 June 
38 Grants of
800 EUR offered